Cardiovascular Dısease Risk in Patients with Obstructıve Sleep Apnea Syndrome
Obstructıve sleep apnea syndrome is a clinical syndrome characterized by recurrent partial or total obstruction of the upper respiratory tract. The main symptoms are snoring, excessive daytime sleepiness and witnessed apnea. It is a disease that affects 3% to 7% of the middle-aged population. Studie...
Main Authors: | Hasan Ölmez, Nurten Arslan Işık |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivano-Frankivsk National Medical University
2019-12-01
|
Series: | Galician Medical Journal |
Subjects: | |
Online Access: | https://ifnmujournal.com/gmj/article/view/1100 |
Similar Items
-
Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases; the Role of Hypertension
by: Yasemin Dinç, et al.
Published: (2022-09-01) -
Relationship Between Obstructive Sleep Apnea and Cardiovascular
by: Debi Febriani, et al.
Published: (2013-06-01) -
Evaluation of obstructive sleep apnea in metabolic syndrome
by: Divya Soin, et al.
Published: (2019-01-01) -
The Risk of Obstructive Sleep Apnea and Daytime Sleepiness
in Patients with Cardiovascular Disease
by: Javad Setareh, et al.
Published: (2018-12-01) -
EFFECT OF FLUOXETINE ON SLEEP ARCHITECTURE IN PATIENTS WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA SYNDROME
by: O. V. Lyubshina, et al.
Published: (2016-01-01)